Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Changes in Stockholders' Equity

v3.26.1
Condensed Consolidated Statements of Changes in Stockholders' Equity - USD ($)
Total
Total The Joint Corp. Stockholders' Equity
Common Stock
Additional Paid In Capital
Treasury Stock
Accumulated Deficit
Non-controlling Interest
Balance, beginning common stock (in shares) at Dec. 31, 2024     15,192,893        
Balance, beginning at Dec. 31, 2024 $ 20,678,119 $ 20,653,119 $ 15,192 $ 49,210,455 $ (870,058) $ (27,702,470) $ 25,000
Balance, beginning treasury stock (in shares) at Dec. 31, 2024         33,015    
Stockholders' Equity [Roll Forward]              
Stock-based compensation expense 293,941 293,941   293,941      
Issuance of restricted stock, net of forfeitures (in shares)     148,565        
Issuance of restricted stock, net of forfeitures 0   $ 149 (149)      
Exercise of stock options (in shares)     3,000        
Exercise of stock options 905,976 905,976 $ 3 905,973      
Purchases of treasury stock under employee stock plans (in shares)         779    
Purchases of treasury stock under employee stock plans (8,440) (8,440)     $ (8,440)    
Net income 967,796 967,796       967,796  
Balance, ending common stock (in shares) at Mar. 31, 2025     15,344,458        
Balance, ending at Mar. 31, 2025 $ 22,837,392 22,812,392 $ 15,344 50,410,220 $ (878,498) (26,734,674) 25,000
Balance, ending treasury stock (in shares) at Mar. 31, 2025         33,794    
Balance, beginning common stock (in shares) at Dec. 31, 2025 14,142,626   15,471,715        
Balance, beginning at Dec. 31, 2025 $ 15,079,592 15,054,592 $ 15,471 52,026,407 $ (12,192,081) (24,795,205) 25,000
Balance, beginning treasury stock (in shares) at Dec. 31, 2025 1,329,089       1,329,089    
Stockholders' Equity [Roll Forward]              
Stock-based compensation expense $ 280,000 280,000   280,000      
Issuance of restricted stock, net of forfeitures (in shares)     258,869        
Issuance of restricted stock, net of forfeitures 0   $ 259 (259)      
Exercise of stock options (in shares)     9,058        
Exercise of stock options 37,228 37,228 $ 9 37,219      
Purchases of treasury stock under employee stock plans (in shares)         5,822    
Purchases of treasury stock under employee stock plans (56,528) (56,528)     $ (56,528)    
Common stock repurchased under authorized repurchase plans (in shares)         137,088    
Common stock repurchased under authorized repurchase plans (1,145,054) (1,145,054)     $ (1,145,054)    
Net income $ 1,299,135 1,299,135       1,299,135  
Balance, ending common stock (in shares) at Mar. 31, 2026 14,267,643   15,739,642        
Balance, ending at Mar. 31, 2026 $ 15,494,373 $ 15,469,373 $ 15,739 $ 52,343,367 $ (13,393,663) $ (23,496,070) $ 25,000
Balance, ending treasury stock (in shares) at Mar. 31, 2026 1,471,999       1,471,999